• The Endpoint Podcast. Episode 29: With Scott Schliebner, VP and Global Head of Drug Development Consulting, Novotech

  • May 15 2024
  • Duración: 43 m
  • Podcast

The Endpoint Podcast. Episode 29: With Scott Schliebner, VP and Global Head of Drug Development Consulting, Novotech Por arte de portada

The Endpoint Podcast. Episode 29: With Scott Schliebner, VP and Global Head of Drug Development Consulting, Novotech

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Scott join Liam on this week’s podcast episode. Scott is VP and Global Head of Drug Development at Novotech. Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase. In todays session we explore Scott’s origin story, discuss it means to him to put patients first, dive into ways we can deliver trials differently and some of his biggest lessons learned over the years in the clinical trial space and much more!
    Más Menos
activate_primeday_promo_in_buybox_DT
Enfermedades Físicas Hygiene & Healthy Living
Más Menos

Lo que los oyentes dicen sobre The Endpoint Podcast. Episode 29: With Scott Schliebner, VP and Global Head of Drug Development Consulting, Novotech

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles